跳至主要内容
临床试验/ACTRN12613001147774
ACTRN12613001147774终止2 期

In women with bacterial vaginosis (BV), does taking the oral contraceptive pill in addition to recommended antibiotic therapy, compared to taking recommended antibiotic therapy alone, reduce the risk of BV recurrence?

The University of Melbourne0 个研究点目标入组 314 人开始时间: 2013年10月15日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
入组人数
314

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Women will be eligible if they:
  • i) Are 18-45 years of age,
  • ii) Are symptomatic with BV, defined as a Nugent score of 4-10 and 3-4 Amsel criteria,

排除标准

  • Women will be ineligible if they are:
  • i) concurrently diagnosed with pelvic inflammatory disease (PID)
  • ii) confirmed to be pregnant at the time of recruitment, or wish to conceive within the next 6 months,
  • iii) known to be HIV positive,
  • iv) unwilling or unable to comply with the requirements of the study protocol,
  • v) already currently using a hormonal method of contraception,
  • vi) known to have contraindications to OCP according to WHO criteria (e.g. focal migraine, history of deep venous thrombosis [DVT], hypertension etc)

研究者

相似试验